Saxon Interests Inc. bought a new position in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 53,627 shares of the company’s stock, valued at approximately $1,077,000.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in BBWI. Royal Bank of Canada lifted its holdings in Bath & Body Works by 92.8% in the 1st quarter. Royal Bank of Canada now owns 59,877 shares of the company’s stock worth $1,815,000 after purchasing an additional 28,815 shares during the last quarter. Goldman Sachs Group Inc. increased its position in Bath & Body Works by 15.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock worth $19,586,000 after buying an additional 87,529 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Bath & Body Works by 7.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company’s stock worth $17,063,000 after buying an additional 36,684 shares during the period. Intech Investment Management LLC bought a new position in Bath & Body Works in the 1st quarter worth approximately $1,155,000. Finally, Geneos Wealth Management Inc. increased its position in Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after buying an additional 801 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several brokerages have commented on BBWI. Citigroup downgraded Bath & Body Works from a “buy” rating to a “neutral” rating and lifted their price target for the stock from $21.00 to $25.00 in a research report on Tuesday, February 17th. Telsey Advisory Group dropped their price target on Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating on the stock in a research report on Thursday, May 28th. Piper Sandler began coverage on Bath & Body Works in a research report on Friday, May 15th. They issued a “neutral” rating and a $20.00 price target on the stock. The Goldman Sachs Group dropped their price target on Bath & Body Works from $26.00 to $23.00 and set a “neutral” rating on the stock in a research report on Thursday, May 28th. Finally, Barclays dropped their price target on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating on the stock in a research report on Thursday, May 28th. Three analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Bath & Body Works has a consensus rating of “Hold” and a consensus target price of $21.93.
Bath & Body Works Trading Up 3.1%
BBWI opened at $19.40 on Friday. The stock has a market cap of $3.91 billion, a PE ratio of 5.45, a P/E/G ratio of 1.87 and a beta of 1.42. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $33.96. The stock’s 50 day simple moving average is $18.61 and its 200-day simple moving average is $20.07.
Bath & Body Works (NYSE:BBWI – Get Free Report) last released its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. The business had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.Bath & Body Works’s quarterly revenue was down 3.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Equities analysts forecast that Bath & Body Works, Inc. will post 2.62 earnings per share for the current fiscal year.
Bath & Body Works Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 19th. Stockholders of record on Friday, June 5th will be given a dividend of $0.20 per share. The ex-dividend date is Friday, June 5th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.1%. Bath & Body Works’s payout ratio is currently 22.47%.
Bath & Body Works Profile
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
See Also
- Five stocks we like better than Bath & Body Works
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
